Xiao-fei Wen

Nuclear magnetic resonance spectroscopy as a new approach for improvement of early diagnosis and risk stratification of prostate cancer

J. Stolzenburg, J. Neuhaus, R. Ganzer, 2017, Journal of Zhejiang University-SCIENCE B.

Effect of E-Cadherin (CDH1) −160C/A polymorphism on prostate cancer risk: a meta-analysis

J. Ouyang, F. Liu, Hui Liu, 2015, bioRxiv.

Chrebp regulates the transcriptional activity of androgen receptor in prostate cancer

B. Liu, Rong-bing Li, Xuelei Wang, 2014, Tumor Biology.

Silencing the expression of Cbl‐b enhances the immune activation of T lymphocytes against RM‐1 prostate cancer cells in vitro

Xiao-fei Wen, Wei-hua Chen, Yue-min Wang, 2014, Journal of the Chinese Medical Association : JCMA.

Role of DNA repair-related gene polymorphisms in susceptibility to risk of prostate cancer.

F. Liu, Hui Liu, Xiao-fei Wen, 2013, Asian Pacific journal of cancer prevention : APJCP.

Insights into Chemoresistance of Prostate Cancer

T. Yang, Na Liu, Wei Zhang, 2015, International journal of biological sciences.

Combination with vorinostat enhances the antitumor activity of cisplatin in castration‐resistant prostate cancer by inhibiting DNA damage repair pathway and detoxification of GSH

Ranlu Liu, Yanming Wang, Xiao-fei Wen, 2022, The Prostate.

UBE3C Promotes Growth and Metastasis of Renal Cell Carcinoma via Activating Wnt/β-Catenin Pathway

H. Chen, Ji Ling Wen, Xiao Fei Wen, 2015, PloS one.

Nuclear magnetic resonance spectroscopy as a new approach for improvement of early diagnosis and risk stratification of prostate cancer

J. Stolzenburg, J. Neuhaus, R. Ganzer, 2017, Journal of Zhejiang University-SCIENCE B.